Paradigm Biocapital Advisors as of Sept. 30, 2022
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 27 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec Call Option (BIIB) | 10.8 | $81M | 305k | 267.00 | |
| Global Blood Therapeutics In | 10.7 | $80M | 1.2M | 68.10 | |
| Mirati Therapeutics | 7.9 | $59M | 850k | 69.84 | |
| Incyte Corporation (INCY) | 6.9 | $52M | 773k | 66.64 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 6.8 | $51M | 497k | 103.26 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 5.9 | $44M | 1.1M | 40.80 | |
| Immunocore Hldgs Ads (IMCR) | 4.8 | $36M | 773k | 46.94 | |
| Miragen Therapeutics (VRDN) | 4.5 | $34M | 1.6M | 20.51 | |
| Argenx Se Sponsored Adr (ARGX) | 4.2 | $32M | 90k | 353.05 | |
| United Therapeutics Corporation (UTHR) | 3.9 | $29M | 141k | 209.38 | |
| Akero Therapeutics (AKRO) | 3.8 | $28M | 833k | 34.05 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.6 | $27M | 1.2M | 23.26 | |
| Syndax Pharmaceuticals (SNDX) | 3.5 | $26M | 1.1M | 24.03 | |
| Axsome Therapeutics (AXSM) | 3.1 | $23M | 520k | 44.62 | |
| Horizon Therapeutics Pub L SHS | 2.9 | $22M | 351k | 61.89 | |
| Alpine Immune Sciences (ALPN) | 2.1 | $16M | 2.2M | 7.20 | |
| Prothena Corp SHS (PRTA) | 1.9 | $14M | 236k | 60.63 | |
| Arvinas Ord (ARVN) | 1.7 | $13M | 284k | 44.49 | |
| Esperion Therapeutics (ESPR) | 1.5 | $12M | 1.7M | 6.70 | |
| Merus N V (MRUS) | 1.5 | $11M | 564k | 20.03 | |
| G1 Therapeutics (GTHX) | 1.5 | $11M | 885k | 12.49 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.4 | $10M | 519k | 19.64 | |
| Oyster Point Pharma | 1.2 | $9.3M | 1.6M | 5.62 | |
| Tg Therapeutics (TGTX) | 1.2 | $8.9M | 1.5M | 5.92 | |
| Poseida Therapeutics I (PSTX) | 1.0 | $7.3M | 2.1M | 3.53 | |
| Vor Biopharma (VOR) | 0.9 | $6.8M | 1.7M | 3.98 | |
| Milestone Pharmaceuticals (MIST) | 0.8 | $5.8M | 634k | 9.19 |
